Speaker

Seymour de Picciotto

CEO, Cellado

Seymour de Picciotto, CEO at Cellado, is speaking at 2nd Oligonucleotide-Based Therapeutics Summit (Boston, United States of America, 8–10 Dec 2026) in the session “Analyzing Emerging Strategies & Future Design Principles for Engineering Extrahepatic Oligonucleotide Delivery”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Upcoming appearances

2nd Oligonucleotide-Based Therapeutics Summit
8–10 Dec 2026Boston, United States of America
- SpeakerAnalyzing Emerging Strategies & Future Design Principles for Engineering Extrahepatic Oligonucleotide Delivery

More speakers at 2nd Oligonucleotide-Based Therapeutics Summit

Julia Alterman
Assistant professor, University of Massachusetts Medical School
Sayantan Chatterjee
Oligonucleotide Chemistry Scientist, Korro Bio
Shuhan Huang
Scientist, WYSS
Cecilia Leung
VP of Research, Vivatides Therapeutics
Stephanie Maiocco
VP of Biotherapeutics, Evercrisp
Thomas Ormsby
Associate Professor, University of Massachusetts Medical School

See all 8 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Seymour de Picciotto, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].